CogState signs $400,000 functional food deal
Monday, 13 February, 2006
CogState (ASX:CGS) is to provide cognition testing services to a European food products company in a contract worth more than AUD$400,000.
Over the next 12 to 15 months, Cogstate will be studying the effect of the European company's dietary product on cognitive function in a trial conducted at the Murdoch Children's Research Institute, Melbourne.
If the trial demonstrates cognitive function enhancement as a result of people consuming its dietary supplement, the food products company will be able to make marketing claims in relation to the product.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
